Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

12.83
-0.3300-2.51%
Volume:167.53K
Turnover:2.16M
Market Cap:220.05M
PE:-1.03
High:13.12
Open:13.09
Low:12.80
Close:13.16
52wk High:31.55
52wk Low:9.40
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.47
T/O Rate:1.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.99
PE(LYR):-0.88

Loading ...

Tonix Pharmaceuticals Files Form 3 for Chief Commercial Officer Thomas Englese

Reuters
·
Sep 08

Tonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

THOMSON REUTERS
·
Sep 08

Tonix Highlights Tonmya Fibromyalgia Launch, Pipeline Progress in Investor Presentation

Reuters
·
Sep 03

Tonix CEO Seth Lederman Acquires 2,000 Common Shares for $27,580

Reuters
·
Aug 31

Tonix Pharma Director Richard H. Bagger Acquires Common Shares Worth $12,600

Reuters
·
Aug 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 24

Tonix Names CEO Seth Lederman Interim Chief Medical Officer

Reuters
·
Aug 19

Tonix Pharmaceuticals: Stronger-Than-Expected Tonmya Launch, Expanded Market Access, and Advancing Pipeline Underpin Buy Rating

TIPRANKS
·
Aug 11

Tonix Pharmaceuticals price target raised to $27 from $25 at Raymond James

TIPRANKS
·
Aug 11

Tonix Pharmaceuticals Holding Corp. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Tonix Pharmaceuticals reports Q2 EPS ($2.44), consensus ($2.62)

TIPRANKS
·
Aug 10

Tonix Q2 Revenue Rises Sharply on Tonmya Launch

Reuters
·
Aug 10

Tonix Q2 FY26 Net Loss Narrows to $40.55 Million; Product Revenue Rises to $13.54 Million

Reuters
·
Aug 10

Tonix Pharmaceuticals Q2 EPS $(2.44) Beats $(2.64) Estimate, Sales $13.544M Beat $7.723M Estimate

Benzinga Earnings
·
Aug 10

Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights

THOMSON REUTERS
·
Aug 10

Tonix Pharmaceuticals Q2 Net Income USD -40.552 Million

THOMSON REUTERS
·
Aug 10

Tonix Pharmaceuticals Holding Corp. Expected to Post a Loss of $2.70 a Share - Earnings Preview

Reuters
·
Aug 08

Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 05

Tonix Publishes Investor Deck Highlighting Tonmya Fibromyalgia Launch and Pipeline Updates

Reuters
·
Aug 04

Tonix Pharmaceuticals receives Type C meeting minutes from FDA for TNX-4800

TIPRANKS
·
Aug 03